Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities between February 26, 2025, and August 4, 2025, of the March 2, 2026, deadline to become lead plaintiffs in a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased agilon securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court by March 2, 2026, to serve as lead plaintiff, representing other class members [3]. - The lawsuit alleges that defendants made false or misleading statements and failed to disclose critical information regarding agilon's financial guidance and business operations, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL